Twist Bioscience ↗
Biotechnology: Biological Products (No Diagnostic Substances) company
Key Metrics of Twist Bioscience
Revenue$245M▲ 20.4% YoYFY 2023
Operating income−$217M▲ 7.5% YoY
Net profit−$205M▲ 6.1% YoY
Shareholders' equity$590M
Market cap$9.6BTWST · $145.25
Competitors10identified
About Twist Bioscience
Sectors
Company details
- Website
- twistbioscience.com
- Founded
- 2018
- Listed
- Nasdaq: TWST (since 2018)
Operational Areas of Twist Bioscience
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameTwist Bioscience Corporation
TickerTWST
ExchangeNasdaq
CountryUnited States
SEC CIK0001581280
Listed since2018
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttps://www.twistbioscience.com
US market & SEC filings
TWST · Nasdaq · SEC CIK 0001581280
Last price · 28 Oct 2026
$145.25
+3.81%
Market cap$9.6B
P/E—On FY 2023 diluted EPS
Volume1,379,873
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited StatesListed 2018
TWST share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeSan Francisco
GSTIN—
Email—
Websitehttps://www.twistbioscience.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Twist Bioscience
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States |
Similar companies
G
GUFIC BIOSCIENCES LIMITEDPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
R
ROSSARI BIOTECH LIMITEDPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Biological E. LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
K
Kbk Biotech Private LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
C
Concord Biotech LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
A
Anthem Biosciences (India)Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
P
Premium Serums & Vaccines Pvt. Ltd. (India)Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
BHARAT SERUMS AND VACCINES LIMITEDPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
biotechnology
Filings
No filings on record yet.